Literature DB >> 2612831

Isotype evolution in the follow-up study of patients with Campylobacter pylori associated gastritis.

B Gobert1, M C Bene, J D de Korwin, G Faure.   

Abstract

Four sequential immuno-assays were performed from May to November 1988 to follow the levels of IgG, IgA and IgM to Campylobacter pylori in 16 infected patients with histologically proven gastritis, among which 12 received appropriate therapy. Histopathological examination of antral biopsies, bacteriological cultures and urease tests were performed on each occasion when serum was tested for antibodies to C. pylori. The detection and quantitative assessment of the various isotypes to this bacterium proved valuable to appreciate the response to therapy with, in case of success, a steady decrease of antibodies levels concomitant with clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612831

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  4 in total

1.  Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection.

Authors:  Y Glupczynski; A Burette; H Goossens; C DePrez; J P Butzler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

2.  Evaluation of a commercially available complement fixation test for diagnosis of Helicobacter pylori infection and for follow-up after antimicrobial therapy.

Authors:  H Goossens; Y Glupczynski; A Burette; C Van den Borre; C DePrez; J Bodenmann; A Keller; J P Butzler
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

3.  Evaluation of a commercial latex test for serological diagnosis of Helicobacter pylori infection in treated and untreated patients.

Authors:  A M Hirschl; M M Hirschl; J Berger; M L Rotter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

4.  Long term serological surveillance after treatment of Helicobacter pylori infection.

Authors:  R A Veenendaal; A S Peña; J L Meijer; H P Endtz; M M van der Est; W van Duijn; F Eulderink; J Kreuning; C B Lamers
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.